Global Sleep Apnea Devices Market to reach $9.43 billion by 2032 with CAGR 6.74%

From GlobeNewswire: 2025-01-21 07:58:00

The Sleep Apnea Devices Market was valued at USD 5.25 billion in 2023, set to reach USD 9.43 billion by 2032 with a CAGR of 6.74%. Factors driving growth include rising cases of sleep apnea, technological advancements, and increased awareness. The market is fueled by demand for non-invasive treatments and government initiatives to raise awareness.

Therapeutic devices accounted for over 65% of the market in 2023, with CPAP machines, BiPAP machines, and oral appliances leading the way. Diagnostic devices are expected to see rapid growth, driven by early diagnosis initiatives. The market is dominated by the 40-60 age group, with older adults showing higher vulnerability to sleep apnea.

North America leads the market with a 49% share in 2023. Major players in the market include ResMed, Respironics, Fisher & Paykel Healthcare, and more. The market is segmented by product, age group, gender, and end-user, with a focus on therapeutic and diagnostic devices. For more information, visit the SNS Insider website. The United States leads the growth of the sleep apnea devices market with high healthcare spending and awareness. Europe follows with steady growth driven by healthcare initiatives. Asia-Pacific sees the fastest growth rate due to increasing prevalence and awareness. Recent developments include ResMed’s AirSense 11 CPAP and Philips’ DreamStation 2, aiming to enhance treatment outcomes.

For more information on the sleep apnea devices market, including statistical insights and trends, competitive landscape, and regional analysis, access the complete report details at SNS Insider. They are a leading market research and consulting agency providing clients with accurate market data and consumer insights to make informed decisions confidently.



Read more at GlobeNewswire: Global Sleep Apnea Devices Market Size to Hit USD 9.43